Navigation Links
New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
Date:3/6/2008

Linda University recounted the application of SpHb to assess an anemic hemoglobin level of 10.6 g/dl on a fellow anesthesiologist who otherwise appeared healthy. Invasive hemoglobin testing confirmed the measurement and further diagnostic testing revealed previously undiagnosed and asymptomatic esophageal cancer. Researchers concluded that Masimo SpHb allowed the "detection of this potentially devastating tumor before clinical signs or symptoms became apparent, which resulted in early intervention and therapy that may well be curative for this colleague."

New Pulse Oximetry Sensors with Low Saturation Accuracy Claims(3), performed by Dr. Peter Cox at the Hospital for Sick Children in Toronto, Canada, evaluated 12 patients with congenital cyanotic cardiac lesions (CCCL) to compare noninvasive oxyhemoglobin (SpO2) measurements from the Masimo Rainbow SET Radical 7 device with Blue Sensor and the Covidien N-600 device (OxiMax with Lo-Sat) to invasive oxyhemoglobin levels from laboratory CO-Oximetry. Although the Nellcor N-600 with LoSat is advertised to work in CCCL patients, the accuracy demonstrated in this study was 6.49%, well outside of Nellcor's published specifications. In contrast, the Masimo Radical with Blue Sensor, the first and only sensor with accuracy claims cleared for cyanotic patients, performed within Masimo specifications and had significantly better accuracy at 3.85%. Study results demonstrate that the Masimo Blue sensor, which was "designed for use specifically in this patient population, is more accurate." Dr. Peter Cox, Hospital for Sick Children in Toronto, Canada, said, "Accurate monitoring of oxygen saturations in children with cyanotic congenital heart defects is essential for appropriate patient management and, therefore, its impact on their long-term outcome. The Masimo Blue Sensor accurately tracks saturation to levels as low as 60%, which will greatly assist caregivers in the management of this patient population."

Severe M
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
2. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
3. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
4. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
5. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
6. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
7. Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
8. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
9. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
10. Treatment of First Patient in Phase I Clinical Trial of Bionomics Anti-Cancer Drug BNC105
11. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  PAREXEL International Corporation (NASDAQ: ... be presenting at the Jefferies Healthcare Conference in New ... President and Chief Financial Officer, will be making a ... p.m. ET on Monday, June 3, 2013. A ... the "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
(Date:5/23/2013)... Mai 2013 Ranbaxy Laboratories ... von Daiichi Sankyo Co., Ltd. (im ... Mai die Maßnahmen bekannt, die Ranbaxy ... um sich der Angelegenheiten der vorhergehenden ... ). Daiichi Sankyo unterstützt ...
(Date:5/22/2013)... -- Team Health Holdings Inc. ("TeamHealth") (NYSE: TMH ... professional staffing and administrative services to hospitals and other ... , today announced that its management team will present ... on May 29, 2013 at the Westin Boston Waterfront. ... Interested investors and other parties may listen to a ...
Breaking Medicine Technology:PAREXEL International To Present At Jefferies Healthcare Conference 2Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2
... Masimo (Nasdaq: MASI ) announced today that ... ended October 2, 2010, after the market closes on November 2, ... begin at 1:30 p.m. PT (4:30 p.m. ET) and will be ... P. de Raad, Executive Vice President and Chief Financial Officer. ...
... MacroGenics, Inc. and Eli Lilly and Company (NYSE: ... Monitoring Committee (DMC), composed of independent experts in the ... analysis of one-year safety and efficacy data of the ... biologic under development for the treatment of individuals with ...
Cached Medicine Technology:Masimo to Report Third Quarter 2010 Financial Results After Market Close on November 2, 2010 2Masimo to Report Third Quarter 2010 Financial Results After Market Close on November 2, 2010 3MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 2MacroGenics and Lilly Announce Pivotal Clinical Trial of Teplizumab Did Not Meet Primary Efficacy Endpoint 3
(Date:5/23/2013)... Angeline Jolie’s brave decision to have both ... an 87% chance she would develop breast cancer is making ... Long term studies show American women have a 12 % ... , Among the things that can be changed to improve ... a day) smoking, and avoiding becoming obese. Choice of diet ...
(Date:5/23/2013)... 2013 With rates of obesity at an ... answers on how to lose weight. Advances in medicine and ... knife in an attempt to shed those extra pounds. Unfortunately ... by the negative health consequences that often accompany them. Now ... undergoing invasive surgery, colon cancer. Diet Doc was ...
(Date:5/23/2013)... 2013 The Assault Hand Paddle ... major milestone in its corporate development. After nearly ... release of the Assault Hand Paddle is an exciting ... Assault Hand Paddle is “revolutionizing paddle sportsmen’s stealth and ... sportsmen seeking stealth and close quarter mobility. The ...
(Date:5/23/2013)... May 23, 2013 Medical device development ... the Sheikh Zayed Institute for Pediatric Surgical Innovation at ... Annual Pediatric Surgical Innovation Symposium will be held June ... It will address critical issues in pediatric surgical ... are available on the Sheikh Zayed Institute website. ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 On May 23, ... research and advocacy, commends Salem High School senior Max Merget ... cancer. , According to a Patch.com article, Max ... with anaplastic ependymoma -- a large malignant tumor in the ... He underwent surgery but the tumor came back a year ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie has Women Asking for Ways to Reduce the Risk of Breast Cancer 2Health News:hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer 2Health News:hCGTreatments/Diet Doc hCG Diet & Weight Loss Plans Now Teach Patients How to Lose Weight Safely and Offer Alternative to Weight Loss Surgery Now Linked to Colon Cancer 3Health News:The Assault Hand Paddle Revolution is On 2Health News:The Assault Hand Paddle Revolution is On 3Health News:Children’s National to Host Symposium on Medical Device Development 2Health News:Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle 2
... Florida,s elected leaders,received a message from thousands ... Governor Charlie Crist and legislative leaders not to,eliminate ... the state,s most,vulnerable citizens., Driven by ambulance ... gurney,the petitions ask Governor Crist, Senate President Ken ...
... Corporation,(Nasdaq: HSKA ) announces the following Webcast:, What: Heska ... Stockholders on the Web, When: Tuesday, ... the Annual Meeting of Stockholders ... over the Internet -- Simply log on to the web at the ...
... a myocardial infarction is not higher for women than ... International (Dtsch Arztebl Int 2008; 105(15): 279-85), PD Dr. ... widely held view. , ( http://www.aerzteblatt-international.de/v4/archiv/pdf.asp?id=59860 ) , ... from AOK (a large general statutory health insurance company) ...
... -- Chindex International,Inc. (Nasdaq: CHDX ) a ... products in the People,s Republic of China, today,announced ... presentations at,the following investment conferences in New York ... All-China Conference being held,from May 19-20, 2008 at ...
... GHX honored 14 healthcare,provider and supplier organizations with its ... awards were,presented on Friday, April 18, 2008 during a ... Chain Summit, the largest healthcare,forum in the U.S. focused ... supply,chain., The theme of this year,s awards was ...
... men and often compresses the urethra resulting in voiding ... to measure the resistance of the urethra using sound: ... spectrum of the recorded sound depends on how much ... with voiding symptoms, such as a weak urinary stream ...
Cached Medicine News:Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 2Health News:Thousands Sign Petitions Urging Governor Crist and Legislative Leaders to Save Healthcare Coverage for 40,000 Floridians 3Health News:Webcast Alert: Heska Corporation's Annual Meeting of Stockholders Webcast 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 2Health News:Chindex International, Inc. to Present at China Investment Conferences in New York City - May 20, 21, 22; Conferences Presented By Brean Murray, Carret & Co., Oppenhiemer & Co. and Citigroup 3Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 2Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 3
CVC 123 is an assayed quality control material used for confirming the calibration and linearity of blood gas, electrolyte, and metabolite instrumentation....
... assayed quality control material used for monitoring the ... It is for specific use on Bayer analyzers ... 288, and 270) and the AVOX Systems CO-Oximeters ... used on the IRMA TRUpoint®. CC 527 is ...
... a quality control material that, once tonometered, ... blood gas, electrolyte, metabolite, and CO-Oximeter instrumentation. ... use of human blood in tonometry. QC ... for monitoring analyzer performance at varying points ...
... is an assayed quality control material ... blood gas, electrolyte, metabolite, and CO-Oximeter ... control makes it the ideal choice ... is available in three (3) levels ...
Medicine Products: